Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. — A-S Belzacq (2001) | RDL Network
Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target.
Article 2001 en
Authors
AB
A-S Belzacq
EJ
E Jacotot
HV
Helena L.A. Vieira
Abstract
1 min read
We report that the photosensitizer verteporfin kills lymphoma cells by an apoptotic process involving a dissipation of the mitochondrial inner transmembrane potential (deltapsim). Light-activated verteporfin-induced apoptosis was abolished by transfection with Bcl-2, a procedure reported to inhibit the mitochondrial permeability transition pore complex (PTPC). Verteporfin triggered the deltapsim loss in isolated mitochondria in vitro, and this effect was suppressed by bongrekic acid and cyclosporin A. Verteporfin plus light also permeabilized proteoliposomes containing the semipurified PTPC or the purified PTPC component adenine nucleotide translocator (ANT), yet had no effect on protein-free control liposomes. Verteporfin phototoxicity on ANT proteoliposomes was mediated by reactive oxygen species and was prevented by recombinant Bcl-2 or the adenine nucleotides ATP and ADP. In conclusion, verteporfin belongs to a class of clinically used chemotherapeutic agents acting on PTPC and ANT.
Étienne Jacotot, L Ravagnan, Markus Loeffler, Karine F. Ferri, Helena L.A. Vieira, Naoufal Zamzami, Paola Costantini, Sabine Druillennec, Johan Hoebeke, Jean Paul Briand, Théano Irinopoulou, Éric Daugas, Santos A. Susín, Denis Cointe, Zhi Hua Xie, John C. Reed, Bernárd P. Roques, Guido Guido Kroemer
Étienne Jacotot, Karine F. Ferri, Chahrazed El Hamel, Catherine Brenner, Sabine Druillennec, Johan Hoebeke, Pierre Rustin, Didier Métivier, C. Lenoir, Maurice Geuskens, Helena L.A. Vieira, Markus Loeffler, Anne-Sophie Belzacq, Jean‐Paul Briand, Naoufal Zamzami, L. Edelman, Zhi Hua Xie, John C. Reed, Bernárd P. Roques, Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.